Anida Pharma Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Anida Pharma General Information
Description
Developer of a biopharmaceutical therapy designed to prevent and slow the progression of ocular disease. The company's platform specializes in a pipeline of treatments that target sensory organ dysfunction with an initial focus on unmet medical needs in pediatric patients, enabling medical professionals to prevent and restore neuro-sensory dysfunction.
Contact Information
Website
www.anidapharma.comCorporate Office
- 155 Brookline Street
- Suite 005
- Cambridge, MA 02139
- United States
Corporate Office
- 155 Brookline Street
- Suite 005
- Cambridge, MA 02139
- United States
Anida Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 21-Dec-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Angel (individual) | 15-Oct-2015 | Cancelled | Clinical Trials - Phase 1 | |||
| 1. Grant | 27-Sep-2013 | Completed | Clinical Trials - Phase 1 |
Anida Pharma Patents
Anida Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025259966-A1 | Pharmaceutical formulations comprising a salt of a docosahexaenoic acid (dha) analog | Pending | 14-Jun-2024 | ||
| US-20250381161-A1 | Compositions and methods for treating hearing and ocular disorders | Pending | 21-Jun-2022 | ||
| WO-2023250031-A1 | Compositions and methods for treating hearing and ocular disorders | Inactive | 21-Jun-2022 | ||
| ES-2773310-T3 | Methods for treating ototoxicity | Active | 28-Feb-2013 | ||
| EP-2961401-A1 | Methods of treating ototoxicity | Active | 28-Feb-2013 | A61K31/202 |
Anida Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CH Innovations | Not-For-Profit Venture Capital | Minority |
Anida Pharma FAQs
-
When was Anida Pharma founded?
Anida Pharma was founded in 2013.
-
Where is Anida Pharma headquartered?
Anida Pharma is headquartered in Cambridge, MA.
-
What industry is Anida Pharma in?
Anida Pharma’s primary industry is Drug Discovery.
-
Is Anida Pharma a private or public company?
Anida Pharma is a Private company.
-
What is Anida Pharma’s current revenue?
The current revenue for Anida Pharma is .
-
Who are Anida Pharma’s investors?
CH Innovations has invested in Anida Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process